Distinct clinical and pathological phenotypes in frontotemporal dementia associated with MAPT, PGRN and C9orf72 mutations

References

• Josephs KA, Hodges JR, Snowden JS, Mackenzie IR, Neumann M, Mann DM, et al. Neuropathological background of phenotypical variability in frontotemporal dementia. Acta Neuropathol. 2011;122:137–53.
   PubMed Web of Science ®Google Scholar
• Seelaar H, Rohrer JD, Pijnenburg YAL, Fox NC, van Swieten JC. Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review. J Neurol Neurosurg Psychiatry. 2011;82:476–86.
   PubMed Web of Science ®Google Scholar
• Bathgate D, Snowden JS, Varma A, Blackshaw A, Neary D. Behaviour in frontotemporal dementia: a comparison with Alzheimer's disease and vascular dementia. Acta Neurol Scand. 2001;103:367–78.
   PubMed Web of Science ®Google Scholar
• Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134:2456–77.
   PubMed Web of Science ®Google Scholar
• Rohrer JD, Rosser MN, Warren JD. Syndromes of non-fluent primary progressive aphasia. A clinical and neurolinguistic analysis. Neurology. 2010;75:603–10.
   PubMed Web of Science ®Google Scholar
• Mesulam M-M, Wieneke C, Thompson C, Rogalski E, Weintraub S. Quantitative classification of primary progressive aphasia at early and mild impairment stages. Brain. 2012;135:1537–53.
   PubMed Web of Science ®Google Scholar
• Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, et al. Association of missense and 5'-splice mutations in tau with the inherited FTDP-17. Nature. 1998;393:702–5.
   PubMed Web of Science ®Google Scholar
• Baker M, Mackenzie IRA, Pickering-Brown SM, Gass J, Rademakers R, Lindholm C, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature. 2006;442:916.
   PubMed Web of Science ®Google Scholar
• De Jesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, et al. Expanded GGGGCC hexanucleotide repeat in non-coding region of C9orf72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245–56.
   PubMed Web of Science ®Google Scholar
• Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs JR, et al. A Hexanucleotide Repeat Expansion in C9orf72 Is the Cause of Chromosome 9p21-Linked ALS-FTD. Neuron. 2011;72:257–68.
   PubMed Web of Science ®Google Scholar
• Janssen JC, Warrington EK, Morris HR, Lantos P, Brown J, Revesz T, et al. Clinical features of frontotemporal dementia due to the intronic tau 10(+16) mutation. Neurology. 2002;58:1161–8.
   PubMed Web of Science ®Google Scholar
• Pickering-Brown SM, Richardson AM, Snowden JS, McDonagh AM, Burns A, Braude W, et al. Inherited frontotemporal dementia in nine British families associated with intronic mutations in the tau gene. Brain. 2002;125:732–51.
   PubMed Web of Science ®Google Scholar
• Pickering-Brown SM, Rollinson S, Du Plessis D, Morrison KE, Varma A, Richardson AM, et al. Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: comparison with patients with MAPT and no known mutations. Brain. 2008;131:721–31.
   PubMed Web of Science ®Google Scholar
• van Swieten JC, Heutink P. Mutations in progranulin (GRN) within the spectrum of clinical and pathological phenotypes of frontotemporal dementia. Lancet Neurol. 2008;7:965–74.
   PubMed Web of Science ®Google Scholar
• Yu C-E, Bird TD, Bekris LM, Montine TJ, Leverenz JB, Steinbart E, et al. The spectrum of mutations in progranulin: a collaborative study screening 545 cases of neurodegeneration. Arch Neurol. 2010;67:161–70.
   PubMed Web of Science ®Google Scholar
• Beck J, Rohrer JD, Campbell T, Isaacs A, Morrison KE, Goodall EF, et al. A distinct clinical, neurological and radiological phenotype is associated with progranulin gene mutations in a large UK series. Brain. 2008;131:706–20.
   PubMed Web of Science ®Google Scholar
• Boeve BF, Boylan KB, Graff-Radford NR, DeJesus-Hernandez M, Knopman DS, Pedraza O, et al. Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9orf72. Brain. 2012;135:765–83.
   PubMed Web of Science ®Google Scholar
• Hsiung G-YR, DeJesus-Hernandez M, Feldman HH, Sengdy P, Bouchard-Kerr P, Dwosh E, et al. Clinical and pathological features of familial frontotemporal dementia caused by C9orf72 mutation on chromosome 9p. Brain. 2012;135:709–22.
   PubMed Web of Science ®Google Scholar
• Snowden JS, Rollinson S, Thompson JC, Harris JM, Stopford CL, Richardson AM, et al. Distinct clinical and pathological characteristics in patients with frontotemporal dementia and C9orf72 mutations. Brain. 2012;135:693–708.
   PubMed Web of Science ®Google Scholar
• van Langenhove T, van der Zee J, Gijselinck I, Engelborghs S, Vandenberghe R, Vandenbulcke M, et al. Distinct Clinical Characteristics of C9orf72 Expansion Carriers Compared With GRN, MAPT, and Nonmutation Carriers in a Flanders-Belgian FTLD Cohort. JAMA Neurol. 2013;70:365–73.
   PubMed Web of Science ®Google Scholar
• Galimberti D, Fenoglio C, Serpente M, Villa C, Bonsi R, Arighi A, et al. Autosomal dominant frontotemporal lobar degeneration due to the C9orf72 hexanucleotide repeat expansion: late-onset psychotic clinical presentation. Biol Psychiatry. 2013;74:384–91.
   PubMed Web of Science ®Google Scholar
• Devenney E, Hornberger M, Irish M, Mioshi E, Burrell J, Tan R, et al. Frontotemporal dementia associated with the C9orf72 mutation. A unique clinical profile. JAMA Neurol. 2014;71:331–9.
   PubMed Web of Science ®Google Scholar
• Le Ber I, Camuzat A, Guillot-Noel L, Hannequin D, Lacomblez L, Golfier V, et al. C9orf72 repeat expansions in the frontotemporal dementias spectrum of diseases: a flowchart for genetic testing. Alzheimers Dis. 2013;34:485–99.
   PubMed Web of Science ®Google Scholar
• Whitwell JL, Weigand SD, Boeve BF, Senjem ML, Gunter JL, DeJesus-Hernandez M, et al. Neuroimaging signatures of frontotemporal dementia genetics: C9orf72, tau, progranulin and sporadics. Brain. 2012;135:794–806.
   PubMed Web of Science ®Google Scholar
• Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51:1546–54.
   PubMed Web of Science ®Google Scholar
• Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, et al. Classification of primary progressive aphasia and its variants. Neurology. 2011;76:1006–14.
   PubMed Web of Science ®Google Scholar
• Snowden JS, Thompson JC, Stopford CL, Richardson AM, Gerhard A, Neary D, et al. Clinical diagnosis of early-onset dementias: diagnostic accuracy and clinicopathological relationships. Brain. 2011;134:2478–92.
   PubMed Web of Science ®Google Scholar
• Mackenzie IR, Neumann M, Bigio EH, Cairns NJ, Alafuzoff I, Kril J, et al. Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration – consensus recommendations: an update. Acta Neuropathol. 2010;119:1–4.
   PubMed Web of Science ®Google Scholar
• Mackenzie IRA, Neumann M, Baborie A, Sampathu DM, DuPlessis D, Jaros E, et al. A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol. 2011;122:111–13.
   PubMed Web of Science ®Google Scholar
• Snowden JS, Pickering-Brown SM, Mackenzie IR, Richardson AM, Varma A, Neary D, et al. Progranulin gene mutations associated with frontotemporal dementia and progressive non-fluent aphasia. Brain. 2006;129:3091–102.
   PubMed Web of Science ®Google Scholar
• Rademakers R, Baker M, Gass J, Adamson J, Huey ED, Momeni P, et al. Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C→T (Arg493X) mutation: an international initiative. Lancet Neurol. 2007;6:857–68.
   PubMed Web of Science ®Google Scholar
• Chen-Plotkin AS, Martinez-Lage M, Sleiman PMA, Hu W, Greene R, Wood EM, et al. Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration. Arch Neurol. 2011;68:488–97.
   PubMed Web of Science ®Google Scholar
• Le Ber I, van der Zee J, Hannequin D, Gijselinck I, Campion D, Puel M, et al. Progranulin null mutations in both sporadic and familial frontotemporal dementia. Hum Mutat. 2007;28:846–55.
   PubMed Web of Science ®Google Scholar
• Dopper EGP, Seelaar H, Chiu WZ, de Koning I, van Minkelen R, Baker MC, et al. Symmetrical Corticobasal Syndrome Caused by a Novel c.314dup Progranulin Mutation. J Mol Neurosci. 2011;45:354–8.
   PubMed Web of Science ®Google Scholar
• Rohrer JD, Ridgway GR, Modat M, Ourselin S, Mead S, Fox NC, et al. Distinct profiles of brain atrophy in frontotemporal lobar degeneration caused by progranulin and tau mutations. Neuroimage. 2010;53:1070–6.
   PubMed Web of Science ®Google Scholar
• Mahoney CJ, Beck J, Rohrer JD, Lashley T, Mok K, Shakespeare T, et al. Frontotemporal dementia with the C9orf72 hexanucleotide repeat expansions: clinical, neuroanatomical and neuropathological features. Brain. 2012;135:736–50.
   PubMed Web of Science ®Google Scholar
• Schymick JC, Yang Y, Andersen PM, Vonsattel JP, Greenway M, Momeni P, et al. Progranulin mutations and amyotrophic lateral sclerosis or amyotrophic lateral sclerosis-frontotemporal dementia phenotypes. J Neurol Neurosurg Psychiatry. 2007;78:754–6.
   PubMed Web of Science ®Google Scholar
• Hodges JR, Mitchell J, Dawson K, Spillantini MJ, Xuereb JH, McMonagle P, et al. Semantic dementia: demography, familial factors and survival in a consecutive series of 100 cases. Brain. 2010;133:300–6.
   PubMed Web of Science ®Google Scholar
• Josephs KA, Duffy JR, Strand EA, Whitwell JL, Layton KF, Parisi JE, et al. Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. Brain. 2006;129:1385–98.
   PubMed Web of Science ®Google Scholar
• Gass J, Cannon A, Mackenzie IR, Boeve B, Baker M, Adamson J, et al. Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Hum Mol Genet. 2006;15:2988–3001.
   PubMed Web of Science ®Google Scholar